---
figid: PMC9376771__WJH-14-1319-g001
pmcid: PMC9376771
image_filename: WJH-14-1319-g001.jpg
figure_link: /pmc/articles/PMC9376771/figure/F1/
number: Figure 1
figure_title: ''
caption: 'Interaction between Bacterial Lipopolysaccharides and Toll-like receptor
  4 signaling pathway in hepatocellular carcinoma development. LPS: Lipopolysaccharides;
  MyD88: Myeloid differentiation primary response protein 88; IRAK1/4: IL-1 receptor
  associated kinase 1/4; TRAF6: TNF receptor associated factor 6; TAK1: TGF-activated
  kinase 1; TAB2/3: TAK1-binding protein 2/3; NEMO: NF-kappa-B essential modulator;
  IKB: Inhibitor of nuclear factor kappa-B; NF-κB: Nuclear factor kappa B.'
article_title: 'Hepatocellular carcinoma and microbiota: Implications for clinical
  management and treatment.'
citation: Dario Spanu, et al. World J Hepatol. 2022 Jul 27;14(7):1319-1332.
year: '2022'

doi: 10.4254/wjh.v14.i7.1319
journal_title: World Journal of Hepatology
journal_nlm_ta: World J Hepatol
publisher_name: Baishideng Publishing Group Inc

keywords:
- Hepatocellular carcinoma
- Gut microbiota
- Gut–liver axis
- Fecal microbiota transplantation
- Carcinogenesis
- Immune checkpoint inhibitors

---
